Please write a SOAP note for a 62-year-old male with hypertension and hyperlipidemia who presents with worsening shortness of breath on exertion, reports no chest pain, occasional cough, takes lisinopril 10 mg daily and atorvastatin 20 mg nightly, and denies smoking.

SOAP Note

Subjective

Chief Complaint: Worsening shortness of breath on exertion

History of Present Illness: 62-year-old male presents with progressive dyspnea on exertion. Denies chest pain, reports occasional cough. No orthopnea, paroxysmal nocturnal dyspnea, or lower extremity edema documented.

Past Medical History:

• Hypertension
• Hyperlipidemia

Medications:

• Lisinopril 10 mg daily
• Atorvastatin 20 mg nightly

Social History: Non-smoker

Review of Systems:

• Cardiovascular: Denies chest pain, palpitations
• Respiratory: Positive for exertional dyspnea, occasional cough
• Constitutional: Denies fever, weight changes

Objective

Vital Signs: [Document BP, HR, RR, SpO2, temperature]

Physical Examination:

• General: [Document appearance, distress level]
• Cardiovascular: [Document heart sounds, murmurs, JVP, peripheral edema]
• Respiratory: [Document breath sounds, crackles, wheezes, work of breathing]
• Extremities: [Document edema, cyanosis, clubbing]

Diagnostic Studies Needed:

• ECG
• Chest radiograph
• BNP or NT-proBNP
• Complete metabolic panel (assess renal function given ACE inhibitor use)
• Complete blood count
• Echocardiogram to assess left ventricular function and valvular disease 1
• Consider cardiopulmonary exercise testing if diagnosis remains unclear 2, 3

Assessment

Primary Differential Diagnoses:

1. Heart failure - Most concerning given age, hypertension, exertional dyspnea pattern. Requires echocardiogram for LVEF assessment 1, 4

2. Coronary artery disease with stable angina equivalent - Exertional symptoms in patient with cardiovascular risk factors (hypertension, hyperlipidemia). Consider stress testing if cardiac biomarkers and echocardiogram do not reveal alternative diagnosis 5

3. Chronic obstructive pulmonary disease or restrictive lung disease - Though patient denies smoking, requires spirometry to exclude 3

4. Deconditioning - Possible but diagnosis of exclusion 3

5. Medication-related - Lisinopril can rarely cause angioedema or cough, though typically presents acutely 6, 7. ACE inhibitor cough is dry and non-productive.

Cardiovascular Risk Assessment:

• Patient has established ASCVD risk factors requiring aggressive management per current guidelines 8
• Current atorvastatin 20 mg is moderate-intensity statin therapy 8

Plan

Diagnostic Workup:

1. Immediate: ECG, chest X-ray, BNP, basic metabolic panel, CBC
2. Urgent: Transthoracic echocardiogram to assess LVEF and structural abnormalities 1
3. If initial workup non-diagnostic: Cardiopulmonary exercise testing to differentiate cardiac vs. pulmonary vs. deconditioning 2, 3
4. If concern for ischemia: Stress testing with imaging (nuclear or echocardiographic) 5

Medication Management:

1. Continue current regimen pending diagnostic evaluation:

   • Lisinopril 10 mg daily - appropriate for hypertension management 9
   • Atorvastatin 20 mg nightly - moderate-intensity statin appropriate for primary prevention with risk factors 8, 10

2. Consider medication adjustments based on findings:

   • If heart failure with reduced ejection fraction identified: Add guideline-directed medical therapy (beta-blocker, consider SGLT2 inhibitor, spironolactone) 1
   • If ischemic heart disease confirmed: Optimize anti-ischemic therapy, consider revascularization evaluation 5
   • If ACE inhibitor-related cough confirmed: Switch to ARB 9

3. Lipid management optimization: Current moderate-intensity statin (atorvastatin 20 mg) provides 30-49% LDL-C reduction 8. If patient has ASCVD or very high-risk features, consider intensification to high-intensity statin (atorvastatin 40-80 mg) targeting ≥50% LDL-C reduction 8, 10

Monitoring:

1. Blood pressure monitoring - assess for orthostatic hypotension given symptoms 9
2. Renal function monitoring on ACE inhibitor 9
3. LDL-C assessment 4-12 weeks after any statin adjustment 10

Patient Education:

1. Seek emergency care immediately if develops chest pain, severe dyspnea at rest, syncope, or lower extremity swelling 11
2. Activity modification pending diagnostic evaluation - avoid strenuous exertion until cardiac evaluation complete 11
3. Medication adherence counseling
4. Lifestyle modifications: dietary sodium restriction, heart-healthy diet, regular moderate exercise as tolerated after clearance 8

Follow-up:

• Return visit in 1-2 weeks to review diagnostic studies and adjust management accordingly
• Cardiology referral if echocardiogram reveals reduced LVEF, significant valvular disease, or if stress testing positive for ischemia 3